Product
Advertisement
SARS-CoV-2 Omicron Detection Antibodies
The Omicron (B.1.1.529) strain is by far the most divergent SARS-CoV-2 variant. It is critical to re-evaluate the effectiveness of the current diagnostics and therapeutics against this new variant. Sino Biological has developed recombinant Omicron Spike and Nucleocapsid proteins and validated all available antibodies against the Omicron proteins.
- Antibody Pairs for the Detection of Omicron Nucleocapsid
Sino Biological has identified seven top pairs of antibodies for the detection of Omicron nucleocapsid protein. - Antibodies for the Detection of Omicron Spike
Sino Biological has screened a panel of previously established spike antibodies for their ability to detect the Omicron nucleocapsid protein.
About Sino Biological
Sino Biological is an international reagent supplier and contract research service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced with a stringent quality management system, and include unique bioreagents addressing areas such as cell therapy, stem cell, and infectious disease research. For example, Sino Biological has a wealth of viral antigens (Provir®) and corresponding antibodies, with one of the world’s Extensive collections. Sino Biological is also a well-recognized, qualified source of recombinant cytokines and high-quality GMP-grade cytokines. In addition, Sino Biological offers contract research production services for the custom development of full length, bioactive proteins and high-affinity antibodies, along with other services. To learn more about Sino Biological visit www.sinobiological.com, follow us on LinkedIn or @SinoInc on Twitter.
Interested in seeing more content from Sino Biological?
Discover all their latest news, webinars, products and more by clicking the link below.
